Literature DB >> 12731377

[Specific-pollen immunotherapy in the treatment of oral allergy syndrome in patients with tree pollen hypersensitivity].

Marek Modrzyński1, Edward Zawisza, Piotr Rapiejko, Grzegorz Przybylski.   

Abstract

UNLABELLED: Over the last three decades several authors have described the existence of an association between sensitivity to different pollens and sensitivity to diverse edible vegetables. Most patients with birch pollen allergy report oral allergy symptoms after eating fresh apples and other vegetable foods. Major birch pollen and apple allergens, Bet v 1 and Mal d 1, and other antigens are highly homologous; as a consequence, pollen-specific immunotherapy (SIT) might be expected to improve apple hypersensitivity. A prospective study was carried out in 27 birch pollen-sensitive patients with apple-induced OAS (oral allergy syndrome) who received injection immunotherapy for 24, or 36 months. Eight patients not submitted to SIT and followed up for 24-36 months were used as a control. Sixteen patients (59%) reported a significant reduction (37%) or a total disappearance (22%) of OAS symptoms after SIT.
CONCLUSION: SIT with birch pollen extracts effectively reduces clinical apple sensitivity in some cases; these effects are not paralleled by a similar reduction of specific IgE and skin reactivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12731377

Source DB:  PubMed          Journal:  Przegl Lek        ISSN: 0033-2240


  3 in total

1.  Difficult management of a patient with pr10 related anaphylaxis.

Authors:  Eleonora Nucera; Arianna Aruanno; Alessandro Buonomo; Simona Mezzacappa; Angela Rizzi; Domenico Schiavino
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

2.  Effect of pollen-specific sublingual immunotherapy on oral allergy syndrome: an observational study.

Authors:  Karl-Christian Bergmann; Hendrik Wolf; Jörg Schnitker
Journal:  World Allergy Organ J       Date:  2008-05       Impact factor: 4.084

3.  Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen-allergic patients with apple allergy.

Authors:  T Kinaciyan; B Nagl; S Faustmann; S Kopp; M Wolkersdorfer; B Bohle
Journal:  Allergy       Date:  2015-11-06       Impact factor: 13.146

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.